StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$27.45−1.09 (-3.82%)

Close on Nov 17, 2026Market cap $1.33BP/E –Yield –

Nanobiotix ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -€9.32M. The highest annual figure on record is -€9.32M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€9.32M–
FY2024Dec 31, 2024-€66.77M–
FY2023Dec 31, 2023-€25.27M–
FY2022Dec 31, 2022-€45.20M–
FY2021Dec 31, 2021-€51.02M–
FY2020Dec 31, 2020-€34.67M–
FY2019Dec 31, 2019-€45.01M–
FY2018Dec 31, 2018-€29.45M–

More Nanobiotix figures

See a number that looks wrong?